Berkshire Biomedical Appoints John E. Timberlake as CEO

Written By Shannon Beyer

DALLAS, April 27, 2021 /PRNewswire/ -- Berkshire Biomedical, LLC ("Berkshire" or "the Company"), a privately-held digital health company developing a revolutionary virtual care prescription drug delivery and management system only for the Intended User, today announced the appointment of John E. Timberlake as President and Chief Executive Officer.

Shannon Beyer
Previous

one8o° Placement Round-Up

Next

Cardiovascular Systems, Inc. Announces Sachin H. Jain, MD, MBA, Joins Board of Directors